Accelerating Drug Discovery With an Automated Single-Cell Workflow
White Paper Apr 08, 2021
Single-cell sequencing is quickly becoming a standard tool in biological research due to the scale and depth of insight it provides across diverse cell populations. The pharmaceutical industry is exploiting single-cell approaches to identify novel therapeutic targets and accelerate promising assets through development.
Consistency and reproducibility are critical throughout the entire drug development process. In the absence of robust workflows, variability in gene expression libraries can be introduced, particularly for long-term studies, research distributed across physical sites and multi-phase global projects.
Download this whitepaper to discover a single-cell workflow that can:
• Produce consistent and reproducible results
• Accelerate drug discovery and development
• Increase productivity and reduce error
Related White Papers
It is paramount within the pharmaceutical industry that scientists can manage large amounts of data efficiently and safely. The Cubis® II balance series was designed for customizable modularity, meeting the needs of the industry whilst maintaining full compliance.
READ MOREAccess this whitepaper to discover a system that performs virtual screening at ultra-high-throughput scale, requires minimal costs and can be run with cloud computing or HPC resources.
READ MOREThe rapid and cost-effective production of conventional monoclonal antibodies (mAbs) for clinical trials has contributed toward their wide adoption. As the number of next-generation antibody-based candidates with modified or absent Fc domains increases, biomanufacturers face a need to establish alternative affinity purification technologies.
READ MORELike what you just read? You can find similar content on the communities below.
Biopharma Cell Science Drug DiscoveryTo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
